- Report
- February 2025
- 100 Pages
Global
From €5418EUR$5,950USD£4,673GBP
- Report
- December 2024
- 120 Pages
Global
From €5418EUR$5,950USD£4,673GBP
- Report
- January 2024
- 125 Pages
Global
From €5418EUR$5,950USD£4,673GBP
From €4462EUR$4,900USD£3,848GBP
- Report
- March 2024
- 200 Pages
Global
From €3779EUR$4,150USD£3,259GBP
- Report
- October 2023
- 145 Pages
Global
From €2868EUR$3,150USD£2,474GBP
- Report
- October 2023
- 145 Pages
Global
From €2868EUR$3,150USD£2,474GBP
- Report
- November 2022
- 230 Pages
Global
From €3415EUR$3,750USD£2,945GBP
- Report
- August 2024
- 82 Pages
Japan
From €3187EUR$3,500USD£2,749GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €2277EUR$2,500USD£1,963GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2732EUR$3,000USD£2,356GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1821EUR$2,000USD£1,571GBP
- Drug Pipelines
- April 2025
- 250 Pages
Global
From €2732EUR$3,000USD£2,356GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£982GBP
- Report
- June 2024
- 200 Pages
Global
From €7239EUR$7,950USD£6,243GBP
- Report
- June 2024
- 200 Pages
Global
From €7239EUR$7,950USD£6,243GBP
- Report
- February 2023
- 30 Pages
Global
From €2504EUR$2,750USD£2,160GBP
- Report
- February 2023
- 30 Pages
Japan
From €2504EUR$2,750USD£2,160GBP
- Report
- February 2023
- 30 Pages
Global
From €2504EUR$2,750USD£2,160GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2504EUR$2,750USD£2,160GBP

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition.
Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more